Icon (ICLR) Liabilities and Shareholders Equity (2009 - 2026)
Icon's (ICLR) quarterly Liabilities and Shareholders Equity came in at $16.4 billion in Q2 2026, down 1.22% year-over-year from $16.6 billion in Q2 2025, and little changed quarter-over-quarter from $16.3 billion in Q1 2026.
Analysis
Icon (ICLR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $16.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 1.22% year-over-year to $16.4 billion in Q2 2026; TTM through Jun 2026 was $65.5 billion, a 2.58% decrease from a year earlier, with the FY2025 full-year figure at $16.3 billion, down 2.54% from the prior year.
- Liabilities and Shareholders Equity was $16.4 billion for Q2 2026 at Icon, roughly flat from $16.3 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $65.7 billion in Q1 2024 and troughed at $16.3 billion in Q4 2025.
- A 5-year average of $19.6 billion and a median of $17.0 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity soared 395.1% in 2022 and tumbled 74.55% in 2025, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $17.3 billion in 2022, then retreated by 2.27% to $16.9 billion in 2023, then retreated by 1.02% to $16.7 billion in 2024, then dropped by 2.54% to $16.3 billion in 2025, then climbed by 0.8% to $16.4 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $16.4 billion (Q2 2026), $16.3 billion (Q1 2026), and $16.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 29.88 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 2.06 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 16.40 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 7.53 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.71 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.83 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 990.05 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 33.29 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12.42 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 3.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.40 Bn |
| Mar 31, 2026 | 16.32 Bn |
| Dec 31, 2025 | 16.27 Bn |
| Sep 30, 2025 | 16.51 Bn |
| Jun 30, 2025 | 16.60 Bn |
| Mar 31, 2025 | 16.72 Bn |
| Dec 31, 2024 | 16.69 Bn |
| Sep 30, 2024 | 17.21 Bn |
| Jun 30, 2024 | 16.97 Bn |
| Mar 31, 2024 | 65.70 Bn |
| Dec 31, 2023 | 16.86 Bn |
| Sep 30, 2023 | 17.03 Bn |
| Jun 30, 2023 | 17.11 Bn |
| Mar 31, 2023 | 17.29 Bn |
| Dec 31, 2022 | 17.26 Bn |
| Sep 30, 2022 | 17.13 Bn |
| Jun 30, 2022 | 17.04 Bn |
| Mar 31, 2022 | 17.16 Bn |
| Dec 31, 2021 | 17.48 Bn |
| Sep 30, 2021 | 17.65 Bn |